Clinical trial
Heparin Induced Thrombocytopenia: Pharmacoeconomics
NCT00456001 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00456001 |
|---|---|
| Title | Heparin Induced Thrombocytopenia: Pharmacoeconomics |
| Official title | Study to Compare the Heparin Induced Thrombocytopenia Rates Associated With Heparin and Low Molecular Weight Heparin Usage as Well as Evaluate the Economic and Long-Term Clinical Burden of Heparin Induced Thrombocytopenia. |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Heparin Induced Thrombocytopenia (HIT) |
| Enrollment | 200 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Apr 4, 2007 |
| Last update posted | Mar 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: